MedTrace Logo

Lower Urinary Tract Symptoms After Intravesical Therapy

NCT05844059 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-05-06

No results posted yet for this study

Summary

With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.

Conditions

  • Chemotherapy Effect
  • Chemotherapeutic Toxicity
  • Lower Urinary Tract Symptoms
  • Overactive Bladder

Interventions

OTHER

Validated questionnaires

BPIC-SS, ICIQ-OABqol, IIEF-EF oder FSFI, ICIQ-MLUTS oder ICIQ-FLUTS

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-21
Primary Completion
2025-04-24
Completion
2026-04-24

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05844059 on ClinicalTrials.gov